Ossiam Acquires 69,313 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Ossiam lifted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9,036.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 70,080 shares of the company’s stock after buying an additional 69,313 shares during the period. Ossiam’s holdings in GE HealthCare Technologies were worth $5,479,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in GEHC. CoreFirst Bank & Trust acquired a new position in GE HealthCare Technologies during the 4th quarter valued at about $25,000. Runnymede Capital Advisors Inc. purchased a new position in shares of GE HealthCare Technologies during the 4th quarter valued at about $28,000. Bank of Jackson Hole Trust acquired a new position in shares of GE HealthCare Technologies in the 4th quarter valued at $32,000. OFI Invest Asset Management purchased a new position in GE HealthCare Technologies during the fourth quarter worth approximately $34,000. Finally, Flagship Wealth Advisors LLC acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at about $34,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

GEHC opened at $62.37 on Friday. The stock’s 50-day moving average price is $79.26 and its 200 day moving average price is $83.03. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The firm has a market cap of $28.56 billion, a price-to-earnings ratio of 14.40, a PEG ratio of 3.19 and a beta of 1.14. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. As a group, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.22%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies’s dividend payout ratio is currently 3.23%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the stock. Citigroup increased their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company upped their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, February 14th. BTIG Research set a $95.00 price objective on GE HealthCare Technologies and gave the stock a “buy” rating in a research report on Monday, April 14th. Finally, The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and upped their target price for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $97.27.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.